Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

This study has been completed.
Sponsor:
Collaborators:
National Institute of Mental Health (NIMH)
Bristol-Myers Squibb
Information provided by (Responsible Party):
Indiana University
ClinicalTrials.gov Identifier:
NCT00870727
First received: February 2, 2009
Last updated: May 14, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)